Prakt. lékáren. 2016; 12(2): 47-49 | DOI: 10.36290/lek.2016.012

Pitfalls opioids in clinical practice

Jana Gregorová1,2, Petra Holečková3,4
1 Oddělení klinické farmacie, Nemocnice Na Bulovce Praha
2 Ústav aplikované farmacie, Farmaceutická fakulta VFU Brno
3 Ústav radiační onkologie, Nemocnice Na Bulovce, Praha
4 1. lékařská fakulta UK Praha

Opioids belong to the treatment of acute and chronic pain. The basic strategy in the selection of appropriate medications and

combinations of the analgetics is determined by standards, WHO analgetic ladder. We can see some problems in clinical practice

associated above all with combinations of opioids and with evaluation of clinically significant drug interactions.

Keywords: acute pain, chronic pain, opioids, combinations of opioids

Published: May 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Gregorová J, Holečková P. Pitfalls opioids in clinical practice. Praktické lékárenství. 2016;12(2):47-49. doi: 10.36290/lek.2016.012.
Download citation

References

  1. Webster L. Efficacy and safety of dual-opioid therapy in acute pain. Pain Medicine. 2012; 13(Suppl 1): S12-20. Go to original source... Go to PubMed...
  2. Mercandante S. Efficacy and safety of dual opioid therapy. Expert opinion on Drug Safety. 2014; 13(11): 1433-1436. Go to original source... Go to PubMed...
  3. Kabelka L, Kozák J, Lejčko J, Sláma O. Doporučený postup pro léčbu průlomové nádorové bolesti. Bolest. 2011; 14, (Supplementum 1).
  4. Turjap M, Dostálek M. Lékové interakce analgetik na úrovni biotransformace. Postgraduální medicína. 2010; 2: 15.
  5. Nieminen TH, Hagelberg NM, et al. Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone. Anesthesiology. 2009; 110(6): 1371-1378. Go to original source... Go to PubMed...
  6. Leštianský B, Hakl M. Strategie opioidní léčby. Neurologie pro praxi. 2010; 11(1): 50-54.




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.